Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
Ready to start engaging on social media? A dermatologist shares tips
- Author:
- Doug Brunk
Think about your goal. Is it to raise awareness of various dermatologic conditions or to grow your business?
News
Multicenter study aims to find new treatments for hidradenitis suppurativa
- Author:
- Doug Brunk
The effort includes collection of biospecimens for translational studies to drive drug development.
News
Systematic review spotlights the use of nutraceuticals for acne
- Author:
- Doug Brunk
Zinc was the most studied nutraceutical, but there was substantial heterogeneity in the results.
News
Adolescents with atopic dermatitis more likely to have experienced bullying, study finds
- Author:
- Doug Brunk
“Clinicians, families, and schools should address and monitor bullying among adolescents.”
News
Treatment options for vitiligo reviewed
- Author:
- Doug Brunk
Principles of vitiligo treatment are to stop immune destruction and to stimulate melanocyte differentiation, migration, and melanin production, Dr...
News
Once-weekly topical therapy shows promise for moderate to severe acne
- Author:
- Doug Brunk
In vitro studies have found that components of S. lacustris, a freshwater sponge, have effects that include antimicrobial activity...
News
3-D stereophotogrammetry helps detect progression of craniofacial morphea
- Author:
- Doug Brunk
Existing tools that detect disease progression in patients with CM are limited.
News
Analysis spotlights economic burden of vitiligo in the U.S.
- Author:
- Doug Brunk
All-cause total healthcare costs for patients with vitiligo were significantly higher than those of matched controls.
News
Choosing which biologic to prescribe for psoriasis
- Author:
- Doug Brunk
In cases of primary failure, consider revisiting the diagnosis, Dr. April Armstrong advised.
News
FDA approves topical roflumilast for psoriasis in children aged 6-11
- Author:
- Doug Brunk
Topical roflumilast was first approved in July 2022 for individuals aged 12 and older.
News
Spironolactone safe, effective option for women with hidradenitis suppurativa
- Author:
- Doug Brunk
“Combining different treatment options that target different pathophysiologic factors is usually required to achieve adequate disease control in...
News
FDA issues letter regarding lebrikizumab review for atopic dermatitis
- Author:
- Doug Brunk
The agency cited concerns related to an inspection of a third-party contract manufacturer.
News
Does the number of primary melanomas affect survival?
- Author:
- Doug Brunk
To compare 10-year melanoma-specific mortality and overall mortality between people with multiple primary melanomas and a single primary melanoma...
News
A glimpse at devices designed to tackle cellulite
- Author:
- Doug Brunk
Development of RAP and targeted verifiable subcision have helped clinicians better understand the makeup of septa, Dr. Ortiz said.
News
Study spotlights paucity of black dermatologists in academia
- Author:
- Doug Brunk
“Greater efforts are needed to recruit Black dermatology graduates into academic faculty positions,” the authors concluded.